🇺🇸 FDA
Patent

US 12018090

PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

granted A61KA61K2039/505A61K2039/54

Quick answer

US patent 12018090 (PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device) held by Rani Therapeutics, LLC expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rani Therapeutics, LLC
Grant date
Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61K, A61K2039/505, A61K2039/54, A61K2039/542, A61K2039/545